Curia's CHO-GSN™ Platform

Published on: 

Sponsored Content

Curia's CHO-GSN™ platform is a stable cell line development service maximizing purity and yield.

Curia offers CHO-GSN™ platform, a CHO stable cell line development service using its proprietary cell line, custom stable expression vectors, and glutamine synthetase (GS) selection technology platform for the generation of a research cell bank and future use manufacturing cell line for commercial products. We offer upstream and downstream process development services coupled with integrated analytical method development. Our platform process is designed to maximize purity and yield, while minimizing the time between development and toxicology studies.